ヒトマイクロバイオームの世界市場予測（～2025年）...市場調査レポートについてご紹介

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Research Approach
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Key Industry Insights
2.3.4 Assumptions

3 Executive Summary (Page No. – 26)

4 Human Microbiome Market : Premium Insights (Page No. – 30)
4.1 Market Overview
4.2 Global Market, By Product (2022)
4.3 Geographic Growth Opportunities
4.4 Geographic Mix
4.5 Developing vs Developed Regions
4.6 Global Research Spending Market, By Technology

5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increased Focus on Human Microbiome Therapy
5.2.1.2 Human Microbiome as New Validated Target for Drug Development
5.2.1.3 Human Microbiome for Early Disease Detection and Diagnosis
5.2.2 Restraints
5.2.2.1 Lack of Expertise and Detailed Research
5.2.2.2 Barriers in Proving the Causal Link Between Dysbiosis and Disease
5.2.3 Opportunities
5.2.3.1 Investigational New Drug (IND) Requirements for Fecal Microbiota
5.2.3.2 Increasing Collaborations Create Growth Opportunities
5.2.4 Challenge
5.2.4.1 Government Regulations
5.2.5 Burning Issues
5.2.5.1 Abundant Opportunities in the Human Microbiome Field and Tremendous Research Investments
5.2.5.2 Development of Human Microbiome Therapeutic Products
5.3 Patents
5.4 Funding

6 Human Microbiome Market, By Product (Page No. – 43)
6.1 Introduction
6.2 Probiotics
6.3 Foods
6.4 Prebiotics
6.5 Medical Foods
6.6 Diagnostic Devices
6.7 Drugs
6.8 Other Probiotic Supplements

7 Human Microbiome Market, By Application (Page No. – 52)
7.1 Introduction
7.2 Therapeutics
7.3 Diagnostics

8 Human Microbiome Market, By Disease (Page No. – 56)
8.1 Introduction
8.2 Acute Diarrhea
8.3 Obesity
8.4 Diabetes
8.5 Autoimmune Disorders
8.6 Cancer
8.7 Mental Disorders
8.8 Other Diseases

9 Human Microbiome Research Spending Market, By Product (Page No. – 65)
9.1 Introduction
9.2 Instruments
9.2.1 Laboratory Instruments
9.2.2 Analyzers
9.3 Consumables
9.3.1 Kits
9.3.2 Reagents

10 Human Microbiome Research Spending Market, By Technology (Page No. – 74)
10.1 Introduction
10.2 Cell Culture Technology
10.3 High-Throughput Technology
10.4 Omics Technology
10.5 Computational Tools

11 Human Microbiome Market, By Region (Page No. – 80)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.4 Asia-Pacific
11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. – 107)
12.1 Overview
12.2 Competitive Situation and Trends
12.2.1 Agreements, Partnerships, and Collaborations
12.2.2 Expansions
12.2.3 Product Launches and Approvals
12.2.4 Other Developments

13 Company Profiles (Page No. – 112)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 Enterome Bioscience
13.2 E.I. Du Pont De Nemours and Company
13.3 Merck & Co., Inc.
13.4 Metabiomics Corporation
13.5 Yakult Honsha Co., Ltd.
13.6 Microbiome Therapeutics, LLC
13.7 Osel, Inc.
13.8 Second Genome, Inc.
13.9 Vithera Pharmaceuticals
13.10 Vedanta Biosciences, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 134)
14.1 Insights From Industry Experts
14.2 Discussion Guide
14.3 Other Developments
14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.5 Introducing RT: Real-Time Market Intelligence
14.6 Available Customizations
14.7 Related Reports
14.8 Author Details